PUBLIC COMPANY
saveSun Pharmaceutical Industries Ltd
updated 2mo ago
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
community read0 votes
🐶 often sniffed alongside
top 8- drugARYNTA31 co-mentions · 10 sources
- drugLISDEXAMFETAMINE DIMESYLATE31 co-mentions · 10 sources
- tagRecall30 co-mentions · 16 sources
- companyOhm Laboratories Inc17 co-mentions · 9 sources
- drugGralise6 co-mentions · 2 sources
- drugNeurontin6 co-mentions · 2 sources
- drugGABAPENTIN6 co-mentions · 2 sources
- tagDrug Shortage4 co-mentions · 4 sources
pipeline
22
marketed
19
phase 3
0
catalysts ytd
18
approvals ytd
10
recalls ytd
2
Pipeline(22)
view full pipeline →pipeline depth22 products
1Preclinical19Marketed1pre_registration1Unknown
Marketed
Absorica
Severe Recalcitrant Nodular Acne
MarketedBynfezia
Acromegaly
MarketedCequa
Keratoconjunctivitis Sicca (Dry Eye)
MarketedFurosemide Sun
Hepatic Edema
MarketedKenalog
Atopic Dermatitis (Atopic Eczema)
MarketedMetronidazole Shanghai Fosun
Abscess
MarketedPindolol Sun Pharma
Hypertension
MarketedStalevo
Parkinson's Disease
MarketedTrivagizole
Vulvovaginal Candidiasis
MarketedUltravate
Plaque Psoriasis (Psoriasis Vulgaris)
MarketedYonsa
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Marketedcalcitriol
Renal Osteodystrophy
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1An Open-Label, Two-Cohort, Pharmacokinetic Study in a Maximal Use Setting for Patients With Actinic Keratosis on the Upper Extremities or the Face
- phase2Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- phase3A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
- phase3Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis
- phase3A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.
- phase2Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
- —Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma
- phase1Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that